- Home
- TBCH vs MNPR Comparison
TBCH vs MNPR Comparison
Compare TBCH & MNPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TBCH
- MNPR
- Stock Information
- Founded
- TBCH 1975
- MNPR 2014
- Country
- TBCH United States
- MNPR United States
- Employees
- TBCH 300
- MNPR N/A
- Industry
- TBCH
- MNPR Biotechnology: Pharmaceutical Preparations
- Sector
- TBCH
- MNPR Health Care
- Exchange
- TBCH NYSE
- MNPR Nasdaq
- Market Cap
- TBCH 269.6M
- MNPR 209.3M
- IPO Year
- TBCH N/A
- MNPR 2019
- Fundamental
- Price
- TBCH $13.98
- MNPR $35.17
- Analyst Decision
- TBCH Buy
- MNPR Strong Buy
- Analyst Count
- TBCH 3
- MNPR 6
- Target Price
- TBCH $14.67
- MNPR $59.60
- AVG Volume (30 Days)
- TBCH 320.6K
- MNPR 55.8K
- Earning Date
- TBCH 08-07-2025
- MNPR 08-08-2025
- Dividend Yield
- TBCH N/A
- MNPR N/A
- EPS Growth
- TBCH N/A
- MNPR N/A
- EPS
- TBCH 0.73
- MNPR N/A
- Revenue
- TBCH $380,819,000.00
- MNPR N/A
- Revenue This Year
- TBCH N/A
- MNPR N/A
- Revenue Next Year
- TBCH $13.56
- MNPR N/A
- P/E Ratio
- TBCH $19.14
- MNPR N/A
- Revenue Growth
- TBCH 45.06
- MNPR N/A
- 52 Week Low
- TBCH $8.78
- MNPR $1.72
- 52 Week High
- TBCH $19.50
- MNPR $54.30
- Technical
- Relative Strength Index (RSI)
- TBCH N/A
- MNPR 51.51
- Support Level
- TBCH N/A
- MNPR $31.17
- Resistance Level
- TBCH N/A
- MNPR $35.01
- Average True Range (ATR)
- TBCH 0.00
- MNPR 2.10
- MACD
- TBCH 0.00
- MNPR 0.11
- Stochastic Oscillator
- TBCH 0.00
- MNPR 46.49
About TBCH TURTLE BEACH CORP
Turtle Beach Corp specializes in gaming accessories, offering a diverse range including headsets, controllers, keyboards, mice, and simulation hardware. With nearly five decades of expertise, it's a innovator in audio technology, particularly dominant in console gaming headsets. Expanding beyond headsets, Turtle Beach now offers game controllers, flight and racing simulation accessories, and high-quality microphones. Operating globally, its products are available through numerous major retailers such as Amazon, Argos, Best Buy, GAME, GameStop, EB Games, Media Markt, Saturn, Target, and Walmart, with a maximum revenue portion generated during the holiday season. The majority of its revenue stems from North America.
About MNPR Monopar Therapeutics Inc.
Monopar Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing proprietary therapeutics designed to extend life or improve the quality of life for cancer patients. The company's pipeline consists of Validive for the prevention of chemoradiotherapy-induced severe oral mucositis in oropharyngeal cancer patients, camsirubicinfor the treatmentof soft tissue sarcoma, a late-stage preclinical antibody, MNPR-101, for cancers and severe COVID-19 and an early-stage camsirubicin analog, MNPR-202, for various cancers.